Cortexyme has received a Notice of Allowance for its US patent application 16/899,376 titled “KETONE INHIBITORS OF LYSINE GINGIPAIN
https://twitter.com/PatentGrants/status/1480618160843681796
Why Are Cortexyme Shares Falling Today?
Cortexyme Inc (NASDAQ:CRTX) has presented additional data from its Phase 2/3 GAIN Trial at the Clinical Trials on Alzheimer’s Disease Conference. …
Cortexyme Reports Its Atuzaginstat Slowed Cognitive Decline In Participants With Alzheimer’s, P. Gingivalis Infection In Phase 2/3 Trial
Evidence supports P. gingivalis as a driver of Alzheimer’s in easily identified patient population
Successful identification of target population and therapeutic dose inform next steps
SOUTH SAN FRANCISCO,
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
Cortexyme To Present Additional Top-Line GAIN Trial Results, Analysis At CTAD 2021 On Nov. 11th
Cortexyme, Inc. (NASDAQ:CRTX) announced that it will participate at the 14th Clinical Trials on Alzheimer's Disease Conference (CTAD 2021) as a part of the meeting's Late-Breaking Readout Roundtable program
71 Biggest Movers From Yesterday
Gainers
Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales results and added $1 billion to its buyback.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Mid-Afternoon Market Update: Nasdaq Surges Over 100 Points; Cortexyme Shares Plunge
Toward the end of trading Wednesday, the Dow traded down 0.23% to 35,674.01 while the NASDAQ rose 0.81% to 15,358.79. The S&P also rose, gaining 0.14% to 4,581.2.